HANCHORBIO
LIVE

Serial Number

90772552

Owner

HanchorBio Inc.

Attorney

Joe McKinney Muncy

Filing Date

Jun 14, 2021

Add to watchlist:

No watchlists yet
View on USPTO

HANCHORBIO Trademark

Serial Number: 90772552 • Registration: 7003113

HANCHORBIO is a trademark filed by HanchorBio Inc. on June 14, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

HanchorBio Inc. (3 trademarks)

5F., No. 42, Ln. 15, Sec. 6,
Taipei City 114 , TW

Entity Type: 16

Trademark Details

Filing Date

June 14, 2021

Registration Date

March 21, 2023

Published for Opposition

January 3, 2023

Goods & Services

Pharmaceutical products and medicines for the treatment of cancers or autoimmune diseases for human use; Reagents for medical diagnostics; Therapeutic reagents for promoting hair growth; Vaccines for human use; Pharmaceutical reagents for medical use, namely, to enhance immunity; Anti-cancer reagents and medicines; Image-forming reagents for medical diagnostics; Western medicines for treating cancers or autoimmune diseases; Chinese medicines for treating cancers or autoimmune diseases; Anti-viral reagents and medicines for treating cancers or autoimmune diseases; Biological reagents and medicines for medical therapeutic use for the treatment of cancers or autoimmune diseases; Protein reagents and medicines for medical therapeutic use for the treatment of cancers or autoimmune diseases; Chemical reagents and medicines for medical therapeutic use for the treatment of cancers or autoimmune diseases; Biological tissue culture reagents for medical therapeutic use for the treatment of cancers or autoimmune diseases; Testing chemicals for medical therapeutic use for the treatment of cancers or autoimmune diseases; Diagnostic reagents for medical therapeutic use; Biomarker diagnostic reagents for medical therapeutic use; Nutritional supplements; Biological reagents for veterinary use

retail and wholesale store services featuring pharmaceutical products; retail and wholesale store services featuring western medicines; retail and wholesale store services featuring Chinese medicines; retail and wholesale store services featuring nutritional supplements; retail and wholesale store services featuring medical equipment

Providing services for biomedical research and development, namely, producing biological medicines; Biological research; Bacteriological research; Providing experimental medicines sample testing and diagnostic services for others for clinical research purposes; Providing reagent sample testing and diagnostic services for others for clinical research purposes; Clinical testing of pharmaceutical medicines for others; Scientific research and analysis of experimental medicines or reagents; Medical research; Product research and development on behalf of other parties; Technical research in the field of pharmaceutical studies; Research for technological programs in the nature of biological drug design; Technical writing, namely, writing of technological documents; industrial analysis and research services; Rental of laboratory equipment for experiments; Service for scientific laboratories; Scientific research; Technological consultancy in the field of biological protein engineering; Scientific research in the field of biological/biomedical protein design and engineering; technical research in the field of biological/biomedical protein design and engineering

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 21, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 21, 2023 R.PR
WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
Jan 19, 2023 ISPO
TEAS DELETE 1(B) BASIS RECEIVED
Jan 17, 2023 D1BR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 3, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 3, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 3, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 3, 2023 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 3, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jan 3, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 14, 2022 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 29, 2022 PREV
ASSIGNED TO LIE
Nov 22, 2022 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 15, 2022 CNSA
ELECTRONIC RECORD REVIEW COMPLETE
Nov 15, 2022 FIXD
DATA MODIFICATION COMPLETED
Nov 15, 2022 DMCC
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Oct 13, 2022 ZZZX
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
May 6, 2022 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
May 3, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 7, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 7, 2022 CRFA
ASSIGNED TO LIE
Apr 4, 2022 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 31, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 8, 2022 GNRN
NON-FINAL ACTION E-MAILED
Mar 8, 2022 GNRT
NON-FINAL ACTION WRITTEN
Mar 8, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 3, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 2, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 1, 2021 NWOS
NEW APPLICATION ENTERED
Jun 17, 2021 NWAP